Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy

  • Yukitoshi Shimoda
  • Rika Hamano
  • Katuhiko Ishihara
  • Noriko Shimoda
  • Norikazu Hagimura
  • Hideo Akiyama
  • Shoji Kishi
  • Akihiro Kaneko
Retinal Disorders

Abstract

Purpose

To investigate the toxic effects of perfusion of intravitreal melphalan during vitrectomy on the rabbit retina.

Methods

We performed electoretinography (ERG) in 18 eyes of 18 healthy albino rabbits before and after intraocular melphalan perfusion at concentrations of 5-, 10-, and 20-μg/ml during pars plana vitrectomy. Fellow eyes that underwent vitrectomy without melphalan served as controls. The histopathologic retinal changes were observed in both eyes of two rabbits from each group.

Results

In the 5-μg/ml perfusion group, the ERGs and histology showed no substantial changes compared with control fellow eyes during 28 days postoperatively. In the 10- and 20-μg/ml groups, the mean a-wave amplitude decreased to 52% and 31% respectively of the fellow eye; the mean b-wave amplitude decreased to 52% and 19% respectively. However, the peak implicit time of the a- and b-waves did not significantly differ in the 10- and 20-μg/ml groups during 28 days postoperatively. Histologic sections showed necrosis of the inner nuclear layer and thinning of the outer nuclear layer in the 10-μg/ml group. Loss of the outer nuclear layer and the photoreceptor layer and necrosis of the inner nuclear layer were observed in the 20-μg/ml group.

Conclusion

The intravitreal 5-μg/ml melphalan perfusion during vitrectomy appears to be nontoxic to the retina. This therapeutic modality might be a potential treatment for retinoblastoma with vitreous seeding.

Keywords

Retinoblastoma Vitreous seeding Melphalan Vitrectomy Retinal toxicity 

References

  1. 1.
    Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823PubMedCrossRefGoogle Scholar
  2. 2.
    Cassady JR, Sagerman RH, Tretter P, Ellsworth RM (1969) Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology 93(2):405–409PubMedGoogle Scholar
  3. 3.
    Sauerwein W, Hopping W, Bornfeld N (1997) Radiotherapy for retinoblastoma. Treatment strategies. Front Radiat Ther Oncol 30:93–96PubMedGoogle Scholar
  4. 4.
    Phillips C, Sexton M, Wheeler G, McKenzie J (2003) Retinoblastoma: review of 30 years’ experience with external beam radiotherapy. Australas Radiol 47(3):226–230PubMedCrossRefGoogle Scholar
  5. 5.
    Scott IU, Murray TG, Feuer WJ, Van Quill K, Markoe AM, Ling S, Roth DB, O’Brien JM (1999) External beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniques. Arch Ophthalmol 117(6):766–770PubMedGoogle Scholar
  6. 6.
    Reese AB, Ellsworth RM (1964) Management of retinoblastoma. Ann N Y Acad Sci 114(2):958–962CrossRefGoogle Scholar
  7. 7.
    Ellsworth RM (1969) The practical management of retinoblastoma. Trans Am Ophthalmol Soc 67:462–534PubMedGoogle Scholar
  8. 8.
    Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling, V, Chan HS (1996) Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114(11):1321–1328PubMedGoogle Scholar
  9. 9.
    Kingston JE, Hungerford JL, Madreperla SA, Plowman PN (1996) Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114(11):1339–1343PubMedGoogle Scholar
  10. 10.
    Murphree AL, Villablanca JG, Deegan WF 3rd, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ (1996) Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114(11):1348–1356PubMedGoogle Scholar
  11. 11.
    Shields CL, De Pdotter P, Himelstein BP, Shields JA, Meadows AT, Maris JM (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114(11):1330–1338PubMedGoogle Scholar
  12. 12.
    Linn Murphree A (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18(1):41–53, viiiPubMedCrossRefGoogle Scholar
  13. 13.
    Yamane T, Kaneko A, Mohri M (2004) The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 9(2):69–73PubMedCrossRefGoogle Scholar
  14. 14.
    Kaneko A, Suzuki S (2003) Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol 33(12):601–607PubMedCrossRefGoogle Scholar
  15. 15.
    Lagendijk JJ (1982) A microwave heating technique for the hyperthermic treatment of tumours in the eye, especially retinoblastoma. Phys Med Biol 27(11):1313–1324PubMedCrossRefGoogle Scholar
  16. 16.
    Inomata M, Kaneko A (1987) Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Jpn J Cancer Res 78(8):858–868PubMedGoogle Scholar
  17. 17.
    Ueda M, Tanabe J, Suzuki T, Sakai H, Mochizuki K, Kitano K, Inomata M, Kaneko A (1994) Conservative therapy for retinoblastoma-effect of melphalan on in vitro electroretinogram. Nippon Ganka Gakkai Zasshi 98(4):352–356PubMedGoogle Scholar
  18. 18.
    Ueda M, Tanabe J, Inomata M, Kaneko A, Kimura T (1995) Study on conservative treatment of retinoblastoma-effect of intravitreal injection of melphalan on the rabbit retina. Nippon Ganka Gakkai Zasshi 99(11):1230–1235PubMedGoogle Scholar
  19. 19.
    Okabe J, Kimura H, Kunou N, Okabe K, Kato A, Ogura Y (2003) Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. Invest Ophthalmol Vis Sci 44(2):740–744PubMedCrossRefGoogle Scholar
  20. 20.
    Marmor MF, Holder GE, Seeliger MW, Yamamoto S (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108(2):107–114PubMedCrossRefGoogle Scholar
  21. 21.
    Shields JA, Shields CL (1990) Treatment of retinoblastoma with cryotherapy. Trans Pa Acad Ophthalmol Otolaryngol 42:977–980PubMedGoogle Scholar
  22. 22.
    Rosengren B, Tengroth B (1977) Retinoblastoma treated with a 60CO applicator. Acta Radiol Ther Phys Biol 16(2):110–116PubMedGoogle Scholar
  23. 23.
    Shields CL, Shields JA, Minelli S, De Potter P, Hernandez C, Cater J, Brady L (1993) Regression of retinoblastoma after plaque radiotherapy. Am J Ophthalmol 115(2):181–187PubMedGoogle Scholar
  24. 24.
    Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr (1997) Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85(14):1121–1128CrossRefGoogle Scholar
  25. 25.
    Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104(12):2101–2111PubMedGoogle Scholar
  26. 26.
    Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT (2000) Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 18(1):12–17PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Yukitoshi Shimoda
    • 1
  • Rika Hamano
    • 1
  • Katuhiko Ishihara
    • 1
  • Noriko Shimoda
    • 1
  • Norikazu Hagimura
    • 1
  • Hideo Akiyama
    • 1
  • Shoji Kishi
    • 1
  • Akihiro Kaneko
    • 2
    • 3
  1. 1.Department of OphthalmologyGunma University School of MedicineGunmaJapan
  2. 2.Second Department of OphthalmologyToho University Medical Center, Ohasi HospitalTokyoJapan
  3. 3.TokyoJapan

Personalised recommendations